Marker Therapeutics, Inc. (MRKR) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues [+]	9.0	1.2	0.5	0.2	0.2	0.2	0.2	0.0
Grants							0.2
Revenue growth	625.9%	166.0%	118.9%	3.5%	12.5%	-8.5%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
Gross profit	9.0	1.2	0.5	0.2	0.2	0.2	0.0	0.0
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	0.0%
Selling, general and administrative [+]	12.8	12.9	10.5	10.0	24.4	6.4	4.7	4.4
General and administrative [+]	12.8	12.9	10.5	10.0	24.4	6.4	4.7	4.4
General and administrative expenses	12.8	12.9	10.5	10.0	24.4	6.4	4.7	4.4
Other selling, general and administrative
Research and development	26.1	27.8	18.9	12.8	8.0	5.3	3.8	1.7
Other operating expenses	0.2	2.4			116.0
EBITDA [+]	-27.4	-39.7	-28.4	-22.4
EBITDA growth	-31.1%	39.9%	26.7%	-84.9%	1190.7%	35.2%	37.9%	82.7%
EBITDA margin	-303.9%	-3200.1%	-6084.2%	-10518.0%	-71930.1%	-6271.1%	-4246.1%
Depreciation and amortization	2.8	2.1	0.5	0.1
EBIT [+]	-30.2	-41.9	-28.9	-22.5	-148.2	-11.5	-8.5	-6.2
EBIT growth	-27.9%	45.0%	28.2%	-84.8%	1190.7%	35.2%	37.9%	82.7%
EBIT margin	-334.8%	-3373.1%	-6188.2%	-10567.3%	-71930.1%	-6271.1%	-4246.1%
Non-recurring items [+]	-0.2	-2.4
Legal settlement	-0.2	-2.4
Interest income, net [+]	0.2	0.0	0.1	1.1	0.3			0.0
Interest expense								0.0
Interest income	0.2	0.0	0.1	1.1	0.3
Other income (expense), net [+]	-0.2	-2.4	0.0	0.0	0.0	0.5	6.0	-27.9
Gain (loss) on debt retirement						0.5		0.0
Gain (loss) on derivative instruments			0.0	0.0	0.0	0.0	5.9	-27.9
Gain (loss) on foreign currency transactions								0.0
Other							0.0
Pre-tax income	-29.9	-41.9	-28.7	-21.4	-148.0	-11.0	-2.5	-34.1
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-29.9	-41.9	-28.7	-21.4	-148.0	-11.0	-2.5	-34.1
Net margin	-332.1%	-3372.7%	-6149.7%	-10050.9%	-71826.3%	-5999.1%	-1227.7%

Basic EPS [+]	($3.58)	($5.47)	($0.61)	($0.47)	($7.75)	($1.16)	($0.36)	($9.30)
Growth	-34.5%	797.0%	29.8%	-93.9%	567.1%	226.0%	-96.2%	365.8%
Diluted EPS [+]	($3.58)	($5.47)	($0.61)	($0.47)	($7.75)	($1.16)	($0.33)	($9.30)
Growth	-34.5%	797.0%	29.8%	-93.9%	567.1%	251.1%	-96.4%	365.8%

Shares outstanding (basic) [+]	8.4	7.7	47.0	45.6	19.1	9.5	6.9	3.7
Growth	9.2%	-83.7%	3.2%	138.8%	102.0%	37.2%	88.1%	-76.3%
Shares outstanding (diluted) [+]	8.4	7.7	47.0	45.6	19.1	9.5	7.4	3.7
Growth	9.2%	-83.7%	3.2%	138.8%	102.0%	27.4%	102.6%	-76.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.